Autopsy report · NCT01283321

RiaSTAP vs. Conventional Transfusion in Patients Having Heart Valve Surgery

“Insufficient funding to complete total projected enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 4 months before it stopped.
• 26 participants enrolled.
• Results were posted on the registry 1 year 9 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Emory University

Sponsor type

University, hospital or other

Conditions

Heart Valve Disease; Coronary Artery Disease

Interventions

Human fibrinogen concentrate; apheresis platelets

Participants

26

Sites

1

Countries

United States

Trials that died the same way

• ALgorithms Adapted From Remote Monitoring
  “Low enrollment, completion of funding” (78% match in meaning)
• BREATHE-Easy Trial
  “Funding completion date passed, inadequate enrollment” (77% match in meaning)
• Feasibility and Acceptability of a Remote Glucose Monitoring Program for Pregnant Marshallese Women
  “Funding ended before enrollment” (75% match in meaning)
• Medical Therapies for Chronic Post-Traumatic Headaches
  “inadequate enrollment, insufficient funds to continue enrollment” (75% match in meaning)
• Registry for Patients Undergoing Pulmonary Procedures
  “funding/ enrollment” (75% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.